ImmuCell Corporation Payments for (Proceeds from) Short-term Investments
ImmuCell Corporation (ICCC) reported Payments for (Proceeds from) Short-term Investments of -$996.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForProceedsFromShortTermInvestments · last filed 2023-03-29
- ImmuCell Corporation payments for (proceeds from) short-term investments for the quarter ending 2021-12-31 was $0.00.
- ImmuCell Corporation payments for (proceeds from) short-term investments for the quarter ending 2021-09-30 was $0.00.
- ImmuCell Corporation payments for (proceeds from) short-term investments for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- ImmuCell Corporation payments for (proceeds from) short-term investments for the quarter ending 2021-03-31 was -$996.00K.
- ImmuCell Corporation payments for (proceeds from) short-term investments for fiscal 2021 was -$996.00K.
- ImmuCell Corporation payments for (proceeds from) short-term investments for fiscal 2020 was -$3.45M.
- ImmuCell Corporation payments for (proceeds from) short-term investments for fiscal 2019 was -$7.67M.
| Period end | Payments for (Proceeds from) Short-term Investments 3 month | Payments for (Proceeds from) Short-term Investments 6 month | Payments for (Proceeds from) Short-term Investments 9 month | Payments for (Proceeds from) Short-term Investments 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $0.00 derived: sum of 2 quarters · filed 2023-03-29 | $0.00 derived: sum of 3 quarters · filed 2023-03-29 | -$996.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-21 | $0.00 derived: sum of 2 quarters · filed 2022-11-21 | -$996.00K 10-Q · filed 2022-11-21 | -$1.99M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2022-11-21 | -$996.00K 10-Q/A · filed 2022-11-21 | -$1.99M derived: sum of 3 quarters · filed 2022-11-21 | -$3.98M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-03-31 | -$996.00K 10-Q/A · filed 2022-11-21 | -$1.99M derived: sum of 2 quarters · filed 2022-11-21 | -$3.98M derived: sum of 3 quarters · filed 2022-11-21 | -$2.48M derived: sum of 4 quarters · filed 2022-11-21 |
| 2020-12-31 | -$996.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$2.99M derived: sum of 2 quarters · filed 2022-03-30 | -$1.48M derived: sum of 3 quarters · filed 2022-03-30 | -$3.45M 10-K · filed 2022-03-30 |
| 2020-09-30 | -$1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$488.00K derived: sum of 2 quarters · filed 2021-11-15 | -$2.45M 10-Q · filed 2021-11-15 | -$7.15M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$461.00K 10-Q · filed 2021-08-12 | -$5.16M derived: sum of 3 quarters · filed 2021-08-12 | -$16.77M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$1.97M 10-Q · filed 2021-05-13 | -$6.66M derived: sum of 2 quarters · filed 2021-05-13 | -$18.27M derived: sum of 3 quarters · filed 2021-05-13 | |
| 2019-12-31 | -$4.69M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$16.31M derived: sum of 2 quarters · filed 2021-03-30 | -$7.67M 10-K · filed 2021-03-30 | |
| 2019-09-30 | -$11.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$2.98M 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $8.64M 10-Q · filed 2020-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |